Fig. 3
From: Targeting REV7 effectively reverses 5-FU and oxaliplatin resistance in colorectal cancer
TLS efficiency is increased in 5-FU and oxaliplatin resistant CRC cells. a Outline of plasmid-based TLS efficiency assay. Procedures was described in “Material and methods” section. b Plasmid-based TLS efficiency analysis in HT29 WT, HT29 5-Fu-R, c SW480 WT, SW480 5-Fu-R, d HT29 Oxa-R and e SW480 Oxa-R. **p < 0.01; ***p < 0.001. The p-values were calculated by using unpaired two-tailed Student's t-test. Variation is indicated and presented as mean ± SEM